spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Cell Line Development and Engineering

Cell Line Development and Engineering

23-25 April 2018
RAI, Amsterdam

Cell Line Development & Engineering 2018 event will be held 23-25 April 2018 in the RAI Amsterdam joining the largest Bioprocessing event in Europe  BPI Europe.

With 900+ attendees, 275+ companies and over 70 sessions showcasing new data and technologies, this year is one not to be missed! Premier industry-led cell line development and engineering event 3 days dedicated to cutting edge science, technologies and strategies:
Day One: Monoclonality & Complex Molecules
Day Two: Cell Line & Host Cell Engineering
Day Three: Automation & Manufacturability Assessment

SIGN UP NOW AND SAVE MORE: https://lifesciences.knect365.com/cell-line-congress/?vip_code=CQ3568EBR

Contact:
T: +44 (0) 20 3377 3279
E: LS.Registrations@Knect365.com 

phone +44 (0) 20 3377 3279
email LS.Registrations@Knect365.com
web bit.ly/2opwE08
email RAI, Amsterdam
 
Print this page
Send to a friend
   
spacer
Industry Events

Pharmaceutical Packaging and Device Labelling Europe

11-12 September 2018, Munich, Germany

Relaunching the event after a three year hiatus, Pharma Packaging and Labelling Europe is back to deliver key, actionable insight on the very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into your packaging and labelling chain with both maximum efficiency and minimal cost. The conference is packed with thought provoking innovative discussions.
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>


News and Press Releases

Aptus Clinical enters into a global partnership agreement with Artelo Biosciences

We are delighted to announce that Aptus Clinical has entered into an agreement with Artelo Biosciences to provide clinical development support the re-purposing of its high-potency dual cannabinoid agonist ART27.13 in oncology.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement